Imunon Inc (IMNN)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $3.85M
Last updated: Nov 17, 2026 at 4:15 PM ET
Imunon Inc (IMNN) Statistics
Imunon (IMNN) has a market cap of $3.85M and an enterprise value of $6.04M. Its share count is up 102.04% from a year earlier. Revenue fell 199.73% over the last 12 months from the 12 months before.
Total Valuation
Enterprise value is 56.83% above the market cap, as debt exceeds cash.
| Market Cap | $3.85M |
|---|---|
| Enterprise Value | $6.04M |
| Latest price (Nov 17, 2026) | $0.61 |
Key Dates
The next earnings report is expected on Mar 29, 2027, covering the quarter ending Dec 31, 2026.
| Next Earnings Date | Mar 29, 2027 (expected) |
|---|---|
| Last Earnings Date | Nov 12, 2026 |
| Fiscal Year End | December |
Price Statistics
The stock is down 85.54% over 52 weeks and trades 45.05% below its 50-day average.
| Beta (1Y) | 0.49 |
|---|---|
| 52-Week Change | -85.54% |
| 1-Month Change | -38.06% |
| 3-Month Change | -61.39% |
| 6-Month Change | -72.64% |
| 5-Year Change | -99.55% |
| 10-Year Change | -99.97% |
| Total Return (1Y) | -85.54% |
| Total Return (3Y CAGR) | -63.40% |
| Total Return (5Y CAGR) | -66.66% |
| Max Drawdown (1Y) | -85.79% |
| Max Drawdown (3Y) | -98.63% |
| Sharpe Ratio (1Y) | -2.83 |
| Correlation with SPY (1Y) | 0.10 |
| 50-Day Average | $1.11 |
| 200-Day Average | $2.07 |
| 52-Week Range | $0.49 to $4.35 |
| RSI (14 Days) | 26.9 |
| Average Volume (20 Days) | 241.96K |
The 5 and 10 year changes compare month-end closes, adjusted for splits, through Oct 2026.
Financial Position
Current assets cover 1.38x current liabilities, and total debt is 2.38x shareholder equity.
| Current Ratio | 1.38x |
|---|---|
| Quick Ratio | 1.38x |
| Debt / Equity | 2.38x |
Returns and Efficiency
Return on invested capital is -131.55% over the last 12 months, against a 5-year average of -95.16%.
| Return on Equity (ROE) | -573.39% |
|---|---|
| Return on Assets (ROA) | -125.21% |
| Return on Invested Capital (ROIC) | -131.55% |
| Return on Capital Employed (ROCE) | -189.70% |
| ROIC (5Y Average) | -95.16% |
Scores
IMNN has a Piotroski F-Score of 3 of 9, in the average band of 3 to 7.
Piotroski F-ScoreWeak at 2 or lessStrong at 8 or more
| Piotroski F-Score | 3 of 9 |
|---|---|
| Piotroski Strength | Average |
Income Statement
Revenue was -$725.20K over the last 12 months.
| Revenue | -$725.20K |
|---|---|
| Revenue Growth (YoY) | -199.73% |
| Gross Profit | -$169.26K |
| Operating Income | -$14.81M |
| Pretax Income | -$15.04M |
| Net Income | -$15.04M |
| EBITDA | -$13.88M |
| EBIT | -$14.74M |
| Reported EPS (TTM) | -$3.32 |
Trailing 12 months through Sep 30, 2026.
Balance Sheet
Shareholder equity funds 21.82% of the $12.01M in total assets.
| Cash and Equivalents | $4.04M |
|---|---|
| Total Debt | $6.23M |
| Net Debt | $2.19M |
| Net Debt Per Share | $0.37 |
| Working Capital | $1.60M |
| Shareholder Equity | $2.62M |
| Book Value Per Share | $0.44 |
| Total Assets | $12.01M |
| Total Liabilities | $9.39M |
Balance sheet as of Sep 30, 2026.
Cash Flow
After $74.46K of capital spending, operating cash flow left -$13.95M of free cash flow.
| Operating Cash Flow | -$13.87M |
|---|---|
| Capital Expenditures | $74.46K |
| Free Cash Flow | -$13.95M |
| FCF Per Share | -$2.49 |
| Depreciation and Amortization | $861.90K |
Trailing 12 months through Sep 30, 2026.
Dividends and Yields
IMNN does not pay a dividend. Its free cash flow yield is -384.33%.
| FCF Yield | -384.33% |
|---|---|
| Buyback Yield | -233.71% |
| Shareholder Yield | -233.71% |
Stock Splits
The last split was a 1-for-15 reverse split on Jul 25, 2025.
| Last Split Date | Jul 25, 2025 |
|---|---|
| Split Type | Reverse split |
| Split Ratio | 1:15 |
Peer Position
Against 3 similar companies, IMNN has the 2nd highest ROIC.
ROICPeer median -156.81%
Revenue Growth (Trailing 4 Quarters, YoY)Peer median -78.57%
| ROIC | -131.55% vs -156.81% median |
|---|---|
| Revenue Growth (Trailing 4 Quarters, YoY) | -199.73% vs -78.57% median |
Price Target
Analyst price targets are part of paid GNG plans. See plans
Frequently Asked Questions About IMNN
What is IMNN's market cap?
Imunon has a market cap of $3.85M. Its enterprise value, which adds debt and subtracts cash, is $6.04M.
How many shares of IMNN are outstanding?
Imunon has 5.95M shares outstanding. The count is up 102.04% from a year earlier.
Does IMNN pay a dividend?
No. Imunon does not pay a dividend.
How much debt does IMNN have?
Imunon has $6.23M of total debt and $4.04M of cash and equivalents, a net debt position of $2.19M.
IMNN pages: Overview, Charting, Earnings, Forecast, Financials, Statistics, Competitors